NCT02175173View on ClinicalTrials.gov

Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome

CompletedOBSERVATIONAL
Enrollment

707

Participants

Timeline

Start Date

June 13, 2013

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions
Lennox-Gastaut Syndrome
Interventions
DRUG

Rufinamide

Administration of Inovelon 100mg or 200mg Tablets

Trial Locations (2)

Unknown

Osaka

Tokyo

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02175173 - Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome | Biotech Hunter | Biotech Hunter